
Researchers from UCLA Health completed a study that suggests increased lipid, or fat, levels in alveolar macrophages can cause pulmonary fibrosis (PF). Their paper, “Impaired Macrophage Lipid Handling Initiates Lung Fibrosis via Lipid-Mediated Fibroblast Activation,” was published in the American Journal of Respiratory Cell and Molecular Biology.
Alveolar macrophages are the lungs’ first line of defense against pathogens and tissue damage. The immune cells are also essential to regulate and repair the lungs. However, when a lipid imbalance occurs, the cells malfunction — losing their protective ability and stimulating disease.
Previous research examined lipid-filled macrophages in lungs with PF, but researchers said this is the first study to determine that the fat imbalance produces the disease rather than being a result of it.
The UCLA team examined mice that didn’t have ABCG1 — the specific protein that controls cholesterol levels in alveolar macrophages. When mice lacked ABCG1, lipids quickly accumulated within the macrophages prior to the occurrence of other biological changes, the researchers reported. This indicates a direct link to pulmonary fibrosis development, as the lipids activated surrounding fibroblast cells to produce scar tissue, they said.
To test the observation, researchers transferred ABCG1-containing macrophages to the mice via bone marrow transplantation. Once normal lipid levels were restored, the macrophages regained functionality and protected the lungs from further fibrotic damage. Conversely, the researchers said, normal mice who were given ABCG1-deficient bone marrow began developing pulmonary fibrosis.
The biggest outcome, researchers noted, was establishing that lipid-filled macrophages produced PF when little to no inflammation or scarring existed. The discovery of the mechanistic sequence of events will change the approach to diagnosing and treating the disease, they said. For example, detecting lipid changes early on can identify patients at increased risk of disease progression and begin treatment sooner to rebalance lipid levels.






















